News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,206 Results
Type
Article (40408)
Company Profile (286)
Press Release (647512)
Section
Business (205044)
Career Advice (2042)
Deals (35527)
Drug Delivery (85)
Drug Development (80932)
Employer Resources (170)
FDA (16142)
Job Trends (14940)
News (346252)
Policy (32641)
Tag
Academia (2611)
Alliances (49446)
Alzheimer's disease (1219)
Approvals (16058)
Artificial intelligence (115)
Bankruptcy (355)
Best Places to Work (11515)
Biotechnology (201)
Breast cancer (101)
Cancer (889)
Cardiovascular disease (76)
Career advice (1708)
Cell therapy (194)
Clinical research (63957)
Collaboration (317)
Compensation (158)
COVID-19 (2553)
Cystic fibrosis (78)
Data (830)
Diabetes (128)
Diagnostics (6203)
Earnings (84263)
Employer resources (148)
Events (109312)
Executive appointments (241)
FDA (16572)
Funding (288)
Gene therapy (147)
GLP-1 (561)
Government (4346)
Healthcare (18751)
Infectious disease (2626)
Inflammatory bowel disease (101)
Interviews (314)
IPO (16304)
Job creations (3709)
Job search strategy (1464)
Layoffs (413)
Legal (7893)
Lung cancer (154)
Manufacturing (149)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19229)
Metabolic disorders (349)
Neuroscience (1458)
NextGen Class of 2024 (6558)
Non-profit (4510)
Northern California (1178)
Obesity (210)
Opinion (180)
Patents (94)
People (56491)
Phase I (19840)
Phase II (28165)
Phase III (21027)
Pipeline (202)
Postmarket research (2559)
Preclinical (8465)
Radiopharmaceuticals (236)
Rare diseases (178)
Real estate (6031)
Regulatory (21566)
Research institute (2382)
Resumes & cover letters (353)
Southern California (1067)
Startups (3615)
United States (11481)
Vaccines (534)
Weight loss (156)
Date
Last 7 days (776)
Last 30 days (2649)
Last 365 days (35700)
2024 (30229)
2023 (40250)
2022 (51416)
2021 (55936)
2020 (54414)
2019 (46902)
2018 (35248)
2017 (32448)
2016 (31873)
2015 (37854)
2014 (31619)
2013 (26711)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (735)
Arizona (188)
Asia (37429)
Australia (6087)
California (2675)
Canada (1167)
China (207)
Colorado (116)
Connecticut (117)
Europe (80042)
Florida (386)
Georgia (104)
Illinois (307)
Indiana (177)
Kansas (95)
Maryland (509)
Massachusetts (2172)
Michigan (142)
Minnesota (248)
New Jersey (810)
New York (828)
North Carolina (661)
Northern California (1178)
Ohio (125)
Pennsylvania (737)
South America (1115)
Southern California (1067)
Texas (374)
Utah (77)
Washington State (318)
688,206 Results for "paladin labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.
June 12, 2023
·
2 min read
Business
Know Labs, Inc. Reports Second Quarter FY 2024 Results
Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024.
May 15, 2024
·
10 min read
Layoffs
Shattuck Labs to Lay Off 40% of Workforce
As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.
October 1, 2024
·
2 min read
·
Angela Gabriel
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Business
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
Know Labs, Inc. today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year 2024 ended on March 31, 2024, on May 15, 2024, beginning at 1:30 pm PT.
May 8, 2024
·
3 min read
BioForest
Know Labs to Present at the American Diabetes Association’s Scientific Sessions
Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results from a clinical research study that assessed the accuracy of Know Labs’ proprietary non-invasive radiofrequency (RF) dielectric sensor in measuring blood glucose.
June 21, 2024
·
6 min read
Business
Know Labs Appoints Chris Somogyi as President, International
Know Labs, Inc. today announced the appointment of Chris Somogyi as President, International.
May 16, 2024
·
5 min read
Business
Hypha Labs Names Craig Ellins Chief Science Officer
Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has made Craig Ellins its Chief Science Officer. Hypha Labs, Inc. changed its name from Digipath, Inc. after the sale of its cannabis lab assets.
April 29, 2024
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
1 of 68,821
Next
